Specified chain length • Defined N/O-sulfation • Counterion-aware documentation
BOC Sciences supports custom heparan sulfate oligosaccharide synthesis for research requiring defined chain length, uronic acid sequence, and N- or O-sulfation patterns. The target specification includes the terminal residues, reducing-end format, counterion, purity criteria, and analytical evidence needed to identify the supplied HS fragment. Total sulfate content is treated separately from the positions of individual sulfo groups.
Labeled schematic of one possible HS tetrasaccharide sequence, not a universal repeat or an activity claim. GlcNS6S specifies N- and 6-O-sulfo groups; IdoA2S specifies a 2-O-sulfo group. Both ends, the final derivative, and ionic form must also be defined.Structure-first project review
Custom glycan synthesis
Heparan sulfate contains alternating uronic acid and glucosamine residues, with structural diversity arising from GlcA/IdoA identity, glucosamine N-substitution, and O-sulfation. A fragment request therefore specifies more than degree of polymerization and total sulfate number. The complete sequence establishes whether two samples are length variants, epimers, positional sulfation isomers, or different derivatives.
The degree of polymerization, or dp, counts monosaccharide residues rather than disaccharide repeats. The sequence states each uronic acid identity, each glucosamine N-substitution, and both chain ends. A chemically defined saturated fragment is distinguished from a lyase-derived fragment with an unsaturated uronic acid end.
Targets can specify GlcNAc or GlcNS at each glucosamine and relevant O-sulfo groups, including uronic acid 2-O and glucosamine 6-O or selected 3-O positions. The requested combination is assessed in its sequence context. An average sulfation level is not equivalent to a single defined pattern.
A series can compare a selected sulfo position, uronic acid epimer, or chain length with the remaining features held as consistent as the structures allow. A reducing-end handle may be included for immobilization or coupling. The linker and final salt form are recorded for each member so that presentation differences remain visible.

Project schematic
Chain length, epimer sequence, sulfo positions, terminal chemistry, and counterion define the HS sample.Target-specific route selection
Chemical and chemoenzymatic approaches are reviewed for the actual HS sequence. Enzyme selectivity can depend on neighboring residues and earlier modifications, while a chemical route depends on a compatible protection and deprotection plan. The order of operations is selected to reach the intended pattern and permit useful purification and assignment, rather than assuming every site can be modified independently.
GlcA and IdoA have the same elemental composition but different stereochemistry. Their placement is part of the target, as is the distinction between N-acetylated and N-sulfated glucosamine. If epimerization is used, the route and analysis must address the desired product rather than report total uronic acid alone.
A chosen O-sulfotransferase or chemical sulfation step does not establish every final position merely from its name. Neighboring N-substitution, epimer identity, accessible groups, and modification order influence the options. Rare or highly specified patterns are reviewed as individual targets with an appropriate assignment strategy.
Highly charged fragments require purification and handling conditions compatible with their sulfo groups and intended supplied form. Desalting, counterion exchange, and residual salt removal affect composition and gravimetric content. The final counterion and water or solvent basis are agreed when needed for concentration or comparison studies.
Structure specification
An HS fragment can have the correct mass and total sulfo count while differing at a key position. The specification layers below connect each requested feature with the information and evidence needed to report it accurately.
| Specification layer | Target definition | Proposed verification | Reporting detail |
|---|---|---|---|
| Chain length and ends | Exact dp, terminal residues, saturated or unsaturated end, and aglycone | Mass and suitable chromatographic and structural analysis | Count monosaccharides; identify extra linker or terminal modifications |
| Sequence and epimers | Position of GlcA/IdoA and GlcNAc/GlcNS residues | NMR assignment and suitable complementary evidence | Equal mass does not resolve uronic acid epimers |
| O-sulfation pattern | Receiving residue and each 2-O, 6-O, or selected 3-O site | Position-sensitive NMR and appropriate orthogonal methods | Total sulfo count is reported separately from site assignment |
| Counterion and content | Named ionic form and relevant water or salt basis | Appropriate counterion/content methods as agreed | State measured composition; do not assume theoretical sodium stoichiometry from a label |
| Purity and related species | Relevant neighboring lengths, under/oversulfated species, and positional variants | Suitable separation and whole-molecule measurements | State method resolution and detection basis; charge purity is not full sequence proof |
Additional derivative formats can be reviewed through our Glycan Modification and Functionalization Services.
Structure-to-data consistency
The analytical package is matched to the sequence and the conclusions required. NMR, suitable chromatography, MS, and carefully selected digestion or composition measurements provide complementary information. Interpretation considers the behavior of highly sulfated molecules during preparation and analysis, including adduct formation or loss of labile groups.
Sequence
Appropriate NMR addresses anomeric connections, uronic acid identity, N-substitution, and O-sulfo placement. Whole-molecule MS supports consistency with chain length and modification count. A sequence assignment is not replaced by an expected mass, and sufficient sample for the requested level of characterization is included in planning.
Composition
Suitable lyase digestion and disaccharide analysis can describe composition when the substrate and method permit. Complete digestion generally removes information about the original order of disaccharides, and some modifications can affect enzyme susceptibility. Composition therefore complements rather than automatically reconstructs the intact sequence.
Ionic form
The report identifies the requested salt form and any agreed counterion, water, residual salt, or content measurements. Gravimetric mass includes more than the carbohydrate anion. Comparisons made on a molar or dry-content basis require the corresponding composition information and method.
Purity
Appropriate separation and mass data assess relevant underextended, under/oversulfated, or other related products. Positional isomers with similar charge can require additional resolution or structural evidence. A single charge-based peak is not presented as proof of every sulfo position or epimer.
Research and method development
Defined fragments help separate the effects of sequence, chain length, and sulfation. Controls are selected around a specific interaction or processing question, with concentration and supplied-form differences considered when comparing samples.
Compare defined sulfo motifs, chain lengths, or uronic acid epimers in protein-binding research. Total negative charge and sequence can both influence the result, so a more highly sulfated fragment is not assumed to be a universally better ligand.
Provide explicitly defined substrates and product comparators for enzyme studies. The full neighboring sequence, terminal state, and modifications are part of substrate identity. A digestion or conversion result is interpreted for the enzyme system actually tested.
Use known fragments to assess NMR assignments, separation, mass interpretation, or digestion workflows. Isomeric controls are useful when position or epimer discrimination is required. A research comparator is not automatically a certified quantitative reference material.
Provide specified ionic forms or handle-bearing fragments for research on concentration, immobilization, or biomolecular presentation. Solubility, binding, and surface behavior depend on the actual formulation and construct and require their own measurements.
A defined research project
The project begins with a residue-level drawing rather than a general heparan sulfate name. Route, analytical scope, and supplied-form requirements are then aligned with the structural distinction that the research needs to test.
Project brief
Provide the full HS sequence, exact dp, GlcA/IdoA identities, all N- and O-substitutions, chain ends, linker, counterion, quantity basis, and required characterization.

Number the residues and define dp, termini, uronic acid epimers, and glucosamine N-substitution. Identify any unsaturated end or artificial reducing-end derivative.

List each O-sulfo position and the intended N-sulfo residues. Select the specific position, epimer, or length variants needed for the comparison.

Assess chemical or chemoenzymatic access, likely related species, and sample requirements for assignment. Include counterion and content analysis where those attributes affect use.

Implement the selected route and purification plan. Complete the agreed supplied-form processing without treating a nominal salt label as a measured composition result.

Provide the sample structure, dp and sulfo map, analytical records, purity basis, and counterion or content information included in the scope. Identify any unresolved analytical distinction explicitly in the report.
Project advantages
BOC Sciences coordinates HS target selection with the measurements required for a meaningful research material. The sequence, modification map, and supplied form remain connected from inquiry through documentation.
Length, epimer identity, N-substitution, and O-sulfo sites are specified independently, avoiding reliance on a broad HS or sulfation label.
Comparison fragments can be designed around a selected site or epimer while recording the other differences that may influence interpretation.
The ionic form and quantity basis are considered alongside structure, helping concentration-dependent studies use the actual supplied material appropriately.
Intact structure, digestion composition, chromatographic purity, and salt/content results are assigned distinct roles in the delivery package.
One connected glycan platform
Related insights
Explore supporting information on structure definition, synthesis, and purification for your glycan research project.
Frequently asked questions
Answers to common questions about structural scope, analytical evidence, and custom synthesis requests.
Use the complete drawing and degree of polymerization, dp, counted as monosaccharide residues. Also identify both chain ends, any unsaturation, and the reducing-end derivative. A disaccharide-repeat count is a different convention and should not be used without explanation.
State GlcNAc versus GlcNS at each glucosamine and every requested O-sulfo position, including the relevant uronic acid 2-O and glucosamine 6-O or selected 3-O sites. Include GlcA/IdoA identity because the same sulfo count can occur on different sequences.
No. It describes an aggregate quantity and does not locate individual groups or resolve uronic acid epimers. Sequence-sensitive structural evidence is needed for a position-defined target. Mass, composition, and chromatography provide complementary information with their own limits.
Not by itself. Digestion can reveal composition when the chosen enzymes process the substrate, but complete digestion generally loses original sequence order. Certain modifications also affect susceptibility. Intact-fragment evidence is needed when sequence or position is the required distinction.
They contribute to the mass of the supplied material and can affect concentration calculations or comparisons. Specify the desired ionic form and whether counterion, water, residual salt, or content measurements are needed. A sodium-salt label alone is not a measured stoichiometric composition.
No. A specific HS oligosaccharide is characterized by its own sequence and format. It is not interchangeable with a heterogeneous heparin preparation, and synthesis does not establish anticoagulant, signaling, or other biological activity. Functional conclusions require the relevant separate study.
Define the molecule your study needs
Send BOC Sciences the HS residue map, sulfo positions, chain ends, and desired counterion. We can review synthetic access, matched fragment controls, purification needs, and the structural and composition records required for your research.
Contact BOC Sciences to discuss the target structure, proposed analytical package, and project-specific specifications. Materials are intended for research use.